covid
Buscar en
Trastornos Adictivos
Toda la web
Inicio Trastornos Adictivos Consumo de tabaco y patología psiquiátrica
Información de la revista
Vol. 9. Núm. 1.
Páginas 31-38 (marzo 2007)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 9. Núm. 1.
Páginas 31-38 (marzo 2007)
Original
Acceso a texto completo
Consumo de tabaco y patología psiquiátrica
Smoking and psychiatric disorders
Visitas
3887
N. Sobradiela, V. García-Vicentb,
Autor para correspondencia
vicentegarcia@fundacionmarbella.org

Correspondencia: V. García Vicent. Comunidad Terapéutica Hacienda de Toros. Carretera de Istán, km.4. 29600 Marbella. Málaga.
a Psicóloga. Hospital Universitario Miguel Servet. Zaragoza. España
b Psiquiatra. Comunidad Terapéutica Hacienda de Toros. Marbella. España
Este artículo ha recibido
Información del artículo
Resumen
Introducción

Existe una relación directa entre la dependencia tabáquica (prevalencia e intensidad) con la presencia de patología psiquiátrica. A menor prevalencia de consumo de tabaco en población general más evidente y relevante se hace esta asociación.

Material y métodos

Se ha realizado una búsqueda bibliográfica en distintas bases científicas, consiguiendo un amplio número de artículos relacionados con el tema del tabaquismo y la patología psiquiátrica.

Resultados

Existe una relación directa y ampliamente comprobada por distintos estudios entre el consumo de tabaco y diferentes patologías psiquiátricas. Las patologías en las que más ampliamente ha sido estudiada esta comorbilidad han sido los trastornos psicóticos, los trastornos afectivos y de ansiedad y el consumo de otras sustancias psicoactivas. En el tratamiento del tabaquismo de pacientes que padecen alguna de estas patologías es conveniente: intensificar y prolongar las intervenciones, poner en práctica técnicas psicoeducativas y cognitivo-conductuales y la utilización de algún tratamiento farmacológico que ayude a controlar y/o reducir la aparición de recaídas en el consumo de tabaco o en la sintomatología psiquiátrica de base. Una pregunta que queda en el aire es el momento en el que iniciar el tratamiento de cesación, aunque se cree que el mejor momento es cuando la patología psiquiátrica esté estabilizada.

Conclusiones

Conviene abordar el consumo de tabaco en los pacientes que padecen patologías psiquiátricas ya que es un grave riesgo de morbimortalidad que, además, disminuye notablemente su calidad de vida.

Palabras clave:
Tabaco
Fumar
Patología psiquiátrica
Diagnóstico dual
Esquizofrenia
Depresión
Alcoholismo
Heroinomanía
Abstract
Introduction

Relationships between tobacco consumption (and nicotine dependence) and the presence of different psychiatric pathologies have been described. The lower smoking prevalence in one population, the stronger this association is.

Material and methods

A bibliographic search on different scientific sources has been performed on the association between smoking and psychiatric disorders.

Results

A direct, strong and thoroughly examined association has been observed on this topic. Psychiatric disorders most strongly associated with tobacco consumption (especially cigarette consumption) are schizophrenia, mayor depression and bipolar disorder, anxiety disorders, and other chemical dependencies. Smoking treatment in these patients requires longer and more intense interventions, where psycho-educative and cognitive-behavioural techniques are performed and where useful pharmacological treatments for smoking cessation are applied. Additional, the evolution of the basal psychiatric disorder should be monitored during the quitting process. Although it has not been clearly established, quitting should be tried when patients are stable in their psychiatric condition.

Conclusions

Smoking consumption should be taken into account in patients with psychiatric pathologies. It is responsible for a high risk of morbidity and mortality in these patients and it greatly decreases their life quality.

Key words:
Tobacco
Smoking
Psychiatric disorders
Dual diagnosis
Schizophrenia
Depresión
Alcohol dependence
Heroin dependence
El Texto completo está disponible en PDF
Bibliografía
[1.]
A. McNeill.
Smoking and mental health: a review of the literature.
Action on Smoking and Health, (2001),
[2.]
C. Brown.
Tobacco and mental health: a review of the literature.
ASH Scotland, (2004),
[3.]
M.C. Pinet, A. Gurrea.
Consumo de tabaco y patología psiquiátrica.
Tratado del Tabaquismo, pp. 165-181
[4.]
K. Lasser, W. Boyd, S. Woolhandler, D.U. Himmelstein, D. McCormick, D.H. Bor.
Smoking and mental illness: a population based prevalence study.
JAMA, 284 (2000), pp. 2606-2610
[5.]
R. West.
Theory of addiction.
Blackwell Publishing, (2006),
[6.]
F.J. Ayesta, M. Rodríguez.
Manual Piufet, (2007),
[7.]
J.L. Coney, T.A. Stevens, N.L. Conney.
Comorbidity of nicotine dependence with psychiatric and substance-use disorders.
Dual diagnosis and treatment, pp. 223-261
[8.]
U. John, C. Meyer, H.J. Rumpf, U. Hapke.
Smoking, nicotine dependence and psychiatric comorbidity--a population-based study including smoking cessation after three years.
Drug Alcohol Depend, 76 (2004), pp. 287-295
[9.]
D. Ziedonis, J.M. Williams, D. Smelson.
Serious mental illness and tobacco addiction: a model program to address this common but neglected issue.
Am J Med Sci, 326 (2003), pp. 223-230
[10.]
M. Poirier, O. Canceil, F. Bayle, B. Millet, M.C. Bourdel, C. Moatti, et al.
Prevalence of smoking in psychiatric patients.
Prog Neuropsychopharmacol Biol Psychiatry, 26 (2002), pp. 529-537
[11.]
S. Brown, H. Inskip, B. Barraclough.
Causes of the excess mortality of schizophrenia.
Br J Psychiatry, 177 (2000), pp. 212-217
[12.]
D. Ziedonis, T. Kosten, W. Glazer, R.J. Frances.
Nicotine dependence and schizophrenia.
Hosp Commun Psychiat, 45 (1994), pp. 204-206
[13.]
O. Jiménez Suárez, E. Castro, S. Camacho.
¿Por qué fuman tanto los esquizofrénicos?.
Psiquiatría Clínica, 11 (1999), pp. 192-195
[14.]
J.M. Martínez-Ortega, M. Gurpegui, F.J. Díaz, J. De León.
Tabaco y esquizofrenia.
Adicciones, 16 (2004), pp. 177-190
[15.]
E. Lyon.
A review of the effects of nicotine on schizophrenia and antipsychotic medications.
Psychiat Serv, 50 (1999), pp. 1346-1350
[16.]
M.C. Fiore, W.C. Bailey, S.J. Cohen, S.F. Dorjman, M.G. Goldstein, E.R. Gritz, et al.
Treating tobacco use and dependence: clinical practice guideline.
US Dept. Health & Human Services, (2000),
[17.]
A.E. Evins, C. Cather, N.A. Rigotti, O. Freudenreich, D.C. Henderson, C.M. Olm-Shipman, et al.
Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction.
J Clin Psychiatry, 307 (2004), pp. 452-453
[18.]
T.P. George, M.J. Sernyak, D.M. Ziedonis, S.W. Woods.
Effects of clozapine on smoking in chronic schizophrenic outpatients.
J Clin Psychiatry, 56 (1995), pp. 344-346
[19.]
K.S. Kendler, M.C. Neale, C.J. McLean, A.C. Heath, L.J. Eaves, R.C. Kessler, et al.
Smoking and major depression. A casual analysis.
Arch Gen Psychiatry, 50 (1993), pp. 36-43
[20.]
N. Breslau, M.M. Kilbey, P. Andreski.
Nicotine dependence and major depression. New evidence from a prospective investigation.
Arch Gen Psychiatry, 50 (1993), pp. 31-35
[21.]
N. Breslau, E.L. Peterson, L.R. Schultz, H.D. Chilcoat, P. Adreski.
Major depression and stages of smoking. A longitudinal investigation.
Arch Gen Psychiatry, 55 (1998), pp. 161-166
[22.]
A. Gurrea, M.C. Pinet.
Tabaco y patología afectiva.
Adicciones, 16 (2004), pp. 155-176
[23.]
B. Borrelli, R. Niaura, N.J. Keuthen, M.G. Goldstein, J.D. DePue, C. Murphy, et al.
Development of major depressive disorder during smoking-cessation treatment.
J Clin Psychiatry, 57 (1996), pp. 534-538
[24.]
L.S. Covey, A.H. Glassman, F. Stetner.
Major depression following smoking cessation.
Am J Psychiatry, 154 (1997), pp. 263-265
[25.]
T. Kinnunen, L. Henning, B.L. Nordstrom.
Smoking cessation in individuals with depression.
CNS Drugs, 11 (1999), pp. 93-103
[26.]
F.J. Ayesta, S. Álvarez, B.M. Benito.
Manual de tabaquismo para profesionales sanitarios.
INGESA-CSBS, (2006),
[27.]
J.G. Johnson, P. Cohen, D.S. Pine, D.F. Klein, S. Kasen, J.S. Brook.
Association between cigarette smoking and anxiety disorders during adolescence and early adulthood.
JAMA, 284 (2000), pp. 2348-2351
[28.]
N. Breslau, D.F. Klein.
Smoking and panic attacks: an epidemiologic investigation.
Arch Gen Psychiatry, 56 (1999), pp. 1141-1147
[29.]
H. Sonntag.
Are social fears and DSM-IV social anxiety disorder associated with smoking and nicotine dependence in adolescents and young adults?.
Eur J Psychiatry, 15 (2000), pp. 67-74
[30.]
S.L. Welch, C.G. Fairburn.
Smoking and bulimia nervosa.
Int J Eat Disord, 23 (1998), pp. 433-437
[31.]
G. Nieva, A. Gual, L. Ortega, S. Mondón.
Alcohol y tabaco.
Adicciones, 16 (2004), pp. 191-199
[32.]
R.M. Mc Cool, K.P. Richter.
Why do so many drug users smoke?.
JSAT, 25 (2003), pp. 43-49
[33.]
D.A. Regier, M.E. Farmer, D.S. Rae, B.Z. Locke, S.J. Keith, L.L. Judd, et al.
Comorbidity of mental disorders with alcohol & other drug abuse. Results from ECA.
JAMA, 264 (1990), pp. 2511-2518
[34.]
D.A. Dawson.
Drinking as a risk factor for sustained smoking.
Drug Alcohol Depend, 59 (2000), pp. 235-249
[35.]
J. Martin, K. Calfas, C. Patten, M. Polarek, C.R. Hofstetter, J. Noto, et al.
Prospective evaluation of three smoking interventions in 205 recovering alcoholics: one-year results of project SCRAP-Tobacco.
J Consulting Clin Psychol, 65 (1997), pp. 190-194
[36.]
A.J. Saxon.
An open trial of transdermal nicotine replacement therapy for smoking cessation among alcohol-and drug-dependent inpatients.
J Subst Abuse Treat, 14 (1997), pp. 333-337
[37.]
A.M. Joseph, D.B. Nelson, S.M. Nugent, M.L. Willembring.
Timing of Alcohol and Smoking Cessation (TASC): smoking among substance use patients screened and enrolled in a clinical trial.
J Addict Dis, 22 (2003), pp. 87-107
[38.]
A.L. Stotts, J.M. Schmitz, J. Grabowski.
Concurrent treatment for alcohol and tobacco dependence: are patients ready to quit both?.
Drug Alcohol Depend, 69 (2003), pp. 1-7
[39.]
D.L. Frosch, S. Shoptaw, D. Nahom, M.E. Jarvik.
Association between tobacco smoking and illicit drug use among methadone-maintained opiatedependent individuals.
Exp Clin Psychopharmacol, 8 (2000), pp. 1-7
[40.]
K.P. Richter, C.A. Gibson, J.S. Ahluwalia, K.H. Schmelzle.
Tobacco use and quit attempts among methadone maintenance clients.
Am J Public Health, 91 (2001), pp. 296-299
[41.]
K.L. Sees, H.W. Clark.
When to begin smoking cessation in substance abusers.
J Substance Abuse Treat, 10 (1993), pp. 189-195
[42.]
M.A. Sullivan, L.S. Covey.
Current perspectives on smoking cessation among substance abusers.
Current Psychiat Rep, 4 (2002), pp. 388-396
[43.]
S. Himelhoch, G. Daumit.
To whom do psychiatrists offer smoking-cessation counselling?.
Am J Psychiatry, 160 (2003), pp. 2228-2230
[44.]
S. Dursun, S. Kutcher.
Smoking, nicotine, and psychiatric disorders: evidence for therapeutic role, controversies, and implications for future research.
Med Hypotheses, 52 (1999), pp. 101-109
[45.]
N. El-Guebaly, J. Cathcart, S. Currie, D. Brown, S. Golster.
Smoking cessation approaches for persons with mental illness or addictive disorders.
Psychiatr Serv, 53 (2002), pp. 1166-1170
[46.]
R.M. Anthenelli.
How-and why-to help psychiatric patients stop smoking.
Curr Psychiat Online, 4 (2005), pp. 1
[47.]
K. Stratton, P. Shetty, R. Wallace, S. Bondurant.
Clearing the smoke: assessing the science base for tobacco reduction.
Institute of Medicine, (2000),
[48.]
J.R. Hughes.
Reduced smoking: an introduction and review of the evidence.
Addiction, 95 (2000), pp. 3-7
[49.]
J.P. Zellweger.
Anti-smoking therapies. Is harm reduction a viable alternative to smoking cessation?.
Drugs, 61 (2001), pp. 1041-1044
[50.]
P. Wennike, T. Danielson, B. Landfelt, A. Westin, P. Tonnensen.
Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up.
Addiction, 98 (2003), pp. 1395-1402
[51.]
K.E. Warner.
Tobacco harm reduction: promise and perils.
Nicotine Tob Res, 3 (2003), pp. 61-71
Copyright © 2007. Elsevier España S.L. y Sociedad Española de Toxicomanías (SET)
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos